WCA
CNCR

Waratah Capital Advisors’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Waratah Capital Advisors’s Portfolio CNCR Stock Details CNCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-13,750
Closed -$332K – 148
2018
Q2 		$332K Buy
+13,750
New +$332K 0.04% 121